Proteinase 3 gene polymorphisms and Wegener's granulomatosis

被引:75
作者
Gencik, M [1 ]
Meller, S
Borgmann, S
Fricke, H
机构
[1] Ruhr Univ Bochum, D-44780 Bochum, Germany
[2] Univ Munich, Klinikum Innenstadt, Med Klin, D-8000 Munich, Germany
关键词
ANCA; Val119lle polymorphism; small vessel vasculitis; systemic autoimmune disease; transcription factor binding site; granulomatous lesions; azurophilic granules;
D O I
10.1046/j.1523-1755.2000.00430.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Wegener's granulomatosis (WG) is a rare systemic autoimmune disease characterized by small-vessel vasculitis leading to organ damage and the presence of antineutrophil cytoplasmic autoantibodies (ANCAs). ANCAs were shown to be involved in the pathogenesis of the disease by increasing adhesion of polymorphonuclear cells (PMNs) to endothelial cells and through activation of primed PMN. The main autoantigen of ANCA in WG is proteinase 3 (PR3), a neutrophil and monocyte-derived neutral serine protease. The association of WG with individuals continuously expressing a high level of PR3 on the surface of PMNs suggests that PR3 variants or altered regulation of PR3 expression might be directly involved in the pathogenesis of the disease. Methods. We screened the entire coding and promoter sequences of the PR3 gene for polymorphisms by means of polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP). Allelic, genotypic, and haplotype frequencies were compared between 79 WG patients and a cohort of 129 healthy controls. Results. Seven single-nucleotide polymorphisms (SNPs), one amino acid change (Val19Ile), one 84 bp insertion/deletion, and a microsatellite were identified. An association with WG could be demonstrated for the A-564G polymorphism in the PR3 promoter affecting a putative transcription factor-binding site. Conclusions. This study excludes certain PR3 epitope variants as autoantigenic stimuli in WG, since the Val119IIe poly morphism showed no differences between patients and controls. Overexpression of PR3, however, might predispose the patient to the development of autoimmune ANCA-associated vasculitis.
引用
收藏
页码:2473 / 2477
页数:5
相关论文
共 27 条
[1]  
BINI P, 1992, J IMMUNOL, V149, P1409
[2]   MULTIPLE ELEMENTS IN HUMAN BETA-GLOBIN LOCUS-CONTROL REGION 5' HS-2 ARE INVOLVED IN ENHANCER ACTIVITY AND POSITION-INDEPENDENT, TRANSGENE EXPRESSION [J].
CATERINA, JJ ;
CIAVATTA, DJ ;
DONZE, D ;
BEHRINGER, RR ;
TOWNES, TM .
NUCLEIC ACIDS RESEARCH, 1994, 22 (06) :1006-1011
[3]   Donor-recipient polymorphism of the proteinase 3 gene: A potential target for T-cell alloresponses to myeloid leukemia [J].
Clave, E ;
Molldrem, J ;
Hensel, N ;
Raptis, A ;
Barrett, AJ .
JOURNAL OF IMMUNOTHERAPY, 1999, 22 (01) :1-6
[4]   Identification of an Sp1-like element within the immunoglobulin kappa 3' enhancer necessary for maximal enhancer activity [J].
Costa, MW ;
Atchison, ML .
BIOCHEMISTRY, 1996, 35 (26) :8662-8669
[5]   STRONG LINK BETWEEN THE ALPHA(1)-ANTITRYPSIN PIZ ALLELE AND WEGENERS GRANULOMATOSIS [J].
ELZOUKI, ANY ;
SEGELMARK, M ;
WIESLANDER, J ;
ERIKSSON, S .
JOURNAL OF INTERNAL MEDICINE, 1994, 236 (05) :543-548
[6]   ALPHA1-ANTITRYPSIN GENETIC-POLYMORPHISM IN ANCA-POSITIVE SYSTEMIC VASCULITIS [J].
ESNAULT, VLM ;
TESTA, A ;
AUDRAIN, M ;
ROGE, C ;
HAMIDOU, M ;
BARRIER, JH ;
SESBOUE, R ;
MARTIN, JP ;
LESAVRE, P .
KIDNEY INTERNATIONAL, 1993, 43 (06) :1329-1332
[7]  
Gencik M, 1999, CLIN EXP IMMUNOL, V117, P412
[8]   The association of CD18 alleles with anti-myeloperoxidase subtypes of ANCA-associated systemic vasculitides [J].
Gencik, M ;
Meller, S ;
Borgmann, S ;
Sitter, T ;
Saecker, AMM ;
Fricke, H ;
Epplen, JT .
CLINICAL IMMUNOLOGY, 2000, 94 (01) :9-12
[9]   BIMODAL DISTRIBUTION OF PROTEINASE-3 (PR3) SURFACE EXPRESSION REFLECTS A CONSTITUTIVE HETEROGENEITY IN THE POLYMORPHONUCLEAR NEUTROPHIL POOL [J].
HALBWACHSMECARELLI, L ;
BESSOU, G ;
LESAVRE, P ;
LOPEZ, S ;
WITKOSARSAT, V .
FEBS LETTERS, 1995, 374 (01) :29-33
[10]   INTERACTION OF SEVERAL RELATED GC-BOX-BINDING AND GT-BOX-BINDING PROTEINS WITH THE INTRONIC ENHANCER IS REQUIRED FOR DIFFERENTIAL EXPRESSION OF THE GB110-GENE IN EMBRYONAL CARCINOMA-CELLS [J].
HAMANN, L ;
BAYER, KU ;
JENSEN, K ;
HARBERS, K .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (09) :5786-5793